Sign In
Buy SBIO
$51.02
+0.710 (+1.41%)
At Close: Jun 03, 2026
Biotech ETF SBIO Rides Strong Momentum into Rate Cuts
08:29am, Thursday, 29'th Aug 2024
While many investors are on the lookout for ETF opportunities in rate cuts, one particular strategy is already standing out. The biotech ETF SBIO is riding some positive momentum thanks to some major
Positive Biotech M&A Activity in 1H Boosts Case for Biotech ETF SBIO
07:56pm, Monday, 19'th Aug 2024
Following some notable uncertainty in recent years, M&A activity looks to be in recovery. In the first half of this year, biotech M&A activity saw some positive numbers, per a new J.P.
Small-Cap ETFs to Rally on Upbeat U.S. Q2 GDP Growth Data?
03:01pm, Friday, 26'th Jul 2024
The US economy expanded at a faster-than-expected pace in the second quarter of 2024. Small-cap stocks generally lead the way higher on improving American economy.
Returns Spiking for This Rate-Sensitive ETF
11:45am, Friday, 19'th Jul 2024
On the lookout for an ETF that might respond particularly well to rate cuts? One rate-sensitive ETF to watch is seeing returns spike even before rate cuts arrive.
The Zacks Analyst Blog KBWR, QQQS, SVAL, EES and SBIO
05:46am, Friday, 19'th Jul 2024
KBWR, QQQS, SVAL, EES and SBIO are included in this Analyst Blog.
5 Small-Cap ETFs at the Forefront of the Latest Rally
12:15pm, Thursday, 18'th Jul 2024
Small-cap stocks have staged a strong comeback buoyed by the Trump trade resurgence and the growing expectations of the Fed cutting rates in September.
Patent Cliffs Could Spark Wave of Biotech M&A
11:42am, Thursday, 18'th Jul 2024
There's long been talk of a new wave of biotech mergers and acquisitions activity coming to life. In modest amounts, there has been evidence of that playing out.
Big Pharma Has the Firepower for Biotech Deal-Making
08:56am, Friday, 14'th Jun 2024
In the early innings of 2024, there was a flurry of consolidation in the biotech industry. It stoked hopes that this would finally be the year in which well-heeled blue-chip pharmaceutical companies w
Biopharma R&D Trends Could Bode Well for This ETF
12:17pm, Tuesday, 07'th May 2024
Many investors hoping for a resurgence by biotech stocks have hitched their wagons to the Federal Reserve lowering interest rates. That's a practical bet because biotech is a rate-sensitive industry.
There Could Be Signs of Life for Biotech ETFs
11:07am, Tuesday, 06'th Feb 2024
Biotech stocks and exchange traded funds have endured a lengthy rough patch. And the pain has been particularly acute for small- and mid-cap fare.
How ETF Investors Can Take Advantage of Deal Activity
11:35am, Thursday, 18'th Jan 2024
With lower interest rates now in sight and renewed confidence in the stock market, deal making activity should pick up in 2024 after a slow couple of years. For retail investors, this could lead to ne
Inside Small-Cap's 3-Year Best Surge in Popularity: ETFs in Focus
02:01pm, Wednesday, 17'th Jan 2024
Wall Street's newfound bullishness on small caps reflects a notable shift in market dynamics, with several analysts predicting continued growth.
What's Now Inside Some Fundamentally Focused ETFs
10:49am, Monday, 08'th Jan 2024
Many of us were prepping for year-end (or on vacation in Belize, in my case) in December. However, index providers were hard at work to ensure certain ETFs fully reflected the investment criteria advi
5 Market-Beating Sector ETFs of December
12:46pm, Friday, 29'th Dec 2023
Wall Street sizzled in December, with all three major indices touching a series of new highs.
Biotech ETF SBIO's Momentum Strong to End 2023
01:40pm, Thursday, 28'th Dec 2023
With the year drawing to a closer, investors may be on the lookout for a strategy or idea that has some momentum. In a notable turnaround from earlier this year, biotech looks to be one such area to c
